Australian Clinical Labs Ltd (AU:ACL) has released an update.
UBS Group AG has officially ceased to be a substantial shareholder in Australian Clinical Labs Ltd as of September 16, 2024, according to a recent filing. This change follows the last notification provided to the company on September 17, 2024. The comprehensive details of the changes in voting securities are outlined in Appendix A of the document.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.
